Professor Marcela Votruba
Professor and Hon. Consultant in Ophthalmology
- votrubam@cardiff.ac.uk
- +44(0)29 2087 0117
- Fax:
- +44 (0)29 2087 4859
- Room 2.30, Optometry and Vision Sciences, Maindy Road, Cathays, Cardiff, CF24 4HQ
- Media commentator
- Available for postgraduate supervision
Overview
Summary
The Mitochondria & Vision Research Group (M Votruba Lab) is interested in the role of mitochondrial dysfunction due to mutation in an expanding number of genes, in the pathophysiology of inherited optic neuropathy. Our approach has placed an emphasis on generating model systems to study retinal ganglion cell (RGC) loss and inner retinal degeneration. The current direction is to explore and evaluate novel therapeutic interventions.
My research spans two themes- Neuroscience and Ageing (https://www.cardiff.ac.uk/optometry-vision-sciences/research/themes/neurodegeneration-and-ageing) and Stem cells, Regeneration and Repair (https://www.cardiff.ac.uk/optometry-vision-sciences/research/themes/stem-cells,-regeneration-and-repair).
It is embedded in two multi-disciplinary research groups- Neurodegeneration to Regeneration (https://www.cardiff.ac.uk/research/explore/research-units/n2r) and Ocular Therapeutics (https://www.cardiff.ac.uk/research/explore/research-units/ocular-therapeutics).
As part of my role as a Clinician Scientist, I also manage patients at the University Hospital Wales Eye Department with inherited eye diseases such as inherited retinal dystrophies and optic neuropathies, running a Retinal Clinic and a Genetic Eye Clinic, at the University Hospital of Wales. I also take part in both commercial and academic clinical research and trials.
Previously I have served as Head of School of Optometry & Vision Sciences for 6 years) (2014-2019).
Research overview
My goals are aimed at developing a deeper understanding of inherited eye disease and ultimately utilising my position as a clinical ophthalmologist to drive the application of translational research in this area. My primary research interest is the pathophysiology of hereditary retinal and optic nerve diseases. I am currently investigating inherited optic neuropathies, which are a pure model of isolated retinal ganglion cell loss. They demonstrate a central role for mitochondria and show some progressive neurodegeneration. Retinal ganglion cells are the cells that make up the nerve of vision, taking impulses from the retina to the brain. Autosomal dominant optic atrophy is the commonest inherited optic neuropathy. It is caused by mutations in the OPA1 gene, leading to visual loss, which first starts in children and young people. Clinical understanding of the disease is poor, although we have clinical and some pathological evidence that retinal ganglion cells are deficient in the eyes of patients. There is no treatment available. Conventional clinical or research strategies have yet to make any clinical impact on this state of affairs. The mechanism of action of the mutant protein OPA1 is not known, but clues exist suggesting that the shape or function of small organelles in the cell, mitochondria, may be involved. Mitochondria are important in generating energy in the cell. Following on from our work to characterise the disease phenotype and clone the disease gene, my group has analysed the spectrum of mutations in the OPA1 gene and genotype/ phenotype correlations. We have performed functional and expression studies of the OPA1 gene and assessed its wider role in inherited optic neuropathy and we are developing model systems to explore the mechanisms and pathways of RGC loss and exploring and testing novel therapies.
Biography
I am a clinically qualified and clinically active Professor of Ophthalmology at Cardiff University School of Optometry & Vision Sciences and an Honorary Consultant Ophthalmologist at the University Hospital of Wales, Cardiff.
I was awarded a Personal Chair at Cardiff University in 2011, having been Senior Lecturer there since 2003. I came to Cardiff from UCL with a Clinician Scientist Fellowship from the MRC, to fund myself and a research associate for four years. Prior to this I was a Consultant in Medical Retina, at Moorfields Eye Hospital, London, UK in 2003 and a Visiting Researcher, at the National Eye Institute, National Institutes of Health, USA, in 2002. I was a fellow to Professor Paul Sieving, in 2002- first in Michigan, Ann Arbor at the Kellogg Eye Centre, and then at the National Eye Institute, National Institutes of Health, Bethesda. I completed my specialty and supra-specialty training in ophthalmology and ophthalmic genetics in 2000 and was awarded my certificate of completion of training. I was a clinical fellow under the guidance of Professors Tony Moore and Alan Bird and trained in medical retina and genetics at a world-leading centre. My fellowship of the Royal College of Ophthalmology (FRCOphth) was awarded in 1992. I studied Physiological Sciences at The Queen’s College, Oxford (BA, MA Hons 2:1, 1984/ 1987), where I was awarded an Open Scholarship in 1981. My Medical degree was at Green College, Oxford (BM BCh, 1987).
Honours and awards
Distinguished Fellowships
Elected Fellow of the Learned Society of Wales in 2017
Research Fellowships
1994 Guide Dogs for the Blind Association Research Fellowship
1998 Wellcome Trust Vision Research Training Fellowship
2002 Frost Research Fellowship
2003 MRC Clinician Scientist Fellowship
Postgraduate Prizes
1996 The Royal Society of Medicine: Ophthalmology Section-Registrars’ Meeting: First Prize (Awarded for the Best Paper at Annual Training Meeting)
Undergraduate Distinctions
1981 Open Scholarship, The Queen’s College, Oxford
1984 First Class Hons. Dissertation, Oxford University
1987 Final Year Clinical Prize: Green College, Green College, Oxford
Professional memberships
Memberships, Affiliations and Societies
European Vision Institute (EVI)
European Paediatric Ophthalmology Society (EPOS)
British Eye Study Group (BESG)
UK Eye Genetics Group (UK EGG)
European Retina, Macula and Vitreous Society (EuroRetina)
Association for Research in Vision & Ophthalmology (ARV0)
International Society of Eye Research (ISER)
European Association for Vision & Eye Research (EVER)
European Society Human Genetics (ESHG)
The Oxford Ophthalmological Congress (OOC)
International Society for Genetic Eye Disease (ISGED)
Academic positions
Present Substantive Appointment
Professor of Ophthalmology, Cardiff University and Consultant in Ophthalmology, Cardiff & Vale NHS Trust, University Hospital Wales
Previous Substantive Appointments
Jan 2014- Dec 2019 Head of School of Optometry & Vision Sciences, Cardiff University
Aug 2011 - Dec 2013 Professor and Honorary Consultant in Ophthalmology, Cardiff University and The Cardiff & Vale NHS Trust, University Hospital of Wales
Oct 2007 - July 2011 Honorary Consultant Senior Lecturer, Cardiff University and The Cardiff & Vale NHS Trust, University Hospital of Wales.
Oct 2003 - Sep 2007 MRC Clinician Scientist Fellow & Honorary Consultant Senior Lecturer, Cardiff University and The University Hospital of Wales
Apr 2003 - Oct 2003 Consultant in Medical Retina, Moorfields Eye Hospital, London & Service Lead for Audit & Clinical Governance & Service Lead for ARMD Research
Other Appointments
2019 Visiting Professor, Charles University Prague, Czech Republic
2002 Visiting Research Scholar, National Eye Institute, National Institutes of Health, Bethesda, MD, USA
Speaking engagements
Invited plenary or keynote lectures at major conferences
- 2016 European Vision & Eye Research Keynote Lecture: Mitochondrial optic neuropathies- new therapies in sight (all expenses paid)
Recent Invited Lectures
2019
- Speaker, Chair and Organiser Royal Society of Medicine Symposium on Mitochondrial Eye Disease, Jan 2019 (all expenses paid)
- Royal College of Ophthalmologists Annual Congress, SIS Speaker, May 2019
- Oxford Medical School Mitochondrial research group inviyed speaker (Nov 2019)
- Optic Nerve Meeting, Obergurgl, speaker, Dec 2019
2018
- Royal College of Ophthalmologists Annual Congress, SIS Speaker
- EVER 2018. SIS Mitochondrial eye disease. Co-Chair. Oct 2018
- South West Ophthalmological Society 2018. Invited Speaker, Nov 2018
- Prague LHON Expert Forum, Invited Speaker and Chair, Dec 2018 (all expenses paid)
- Japan Exchange, speaker Dec 2018 (all expenses paid)
2017
- MRC Mary Lyons Centre, Harwell, Oxfordshire, March 2017 (all expenses paid).
- ARVO 2017: Special Interest Symposium Co-Chair, Mitochondrial optic neuropathies, May 2017.
- The Royal College of Ophthalmologists Annual Congress - invited speaker at SIS Neurodegeneration & the Eye, May 2017, Liverpool.
- Barcelona, EUPON Invited Speaker, March 2017 (all expenses paid).
- EVER 2017. SIS Mitochondrial eye disease. Co-Chair. Oct 2017
2016
- European Optic Nerve Meeting, Milan, Italy (all expenses paid)
- Cambridge Ophthalmological Symposium, Cambridge (all expenses paid)
- Welsh School of Pharmacy Seminar: Mitochondrial optic neuropathy- pathophysiological insights and novel therapeutic interventions
- EVER Keynote Lecture: Mitochondrial optic neuropathies- new therapies in sight. (all expenses paid)
Invited Faculty
2018 Expert Panel Mitochonrial optic neuropathies, Santhera, Prague
2013 European Neuromuscular Consortium, Naarden, Holland
2012 European Professors of Ophthalmology, Leuven, Belgium
2009 Keystone Symposium: Mitochondrial Dynamics and Physiology, Whistler, Canada
2008 Great Ormond Street Hospital/ Moorfields Paediatric Ophthalmology Course
2007 Great Ormond Street Hospital/ Moorfields Paediatric Ophthalmology Course
2006 Great Ormond Street Hospital/ Moorfields Paediatric Ophthalmology Course
2004 The European University Professors in Ophthalmology (EUPO), Nijmegen
2003 The Cambridge Ophthalmological Symposium, Cambridge
2001 The Electrophysiology of Vision Course, Moorfields Eye Hospital, London
Committees and reviewing
Grant advisory panels
- 2020-2025 Deputy Chair, Fight for Sight Grant Advisory Panel, UK
- 2015 – 2020 Member Grant Advisor Panel, National Eye Research Centre, UK
- 2017– 2020 Member Grant Advisory Board, RP Fighting Blindness/ Retina UK
- 2012 – 2017 Member Grant Advisory Panel, Fight for Sight, UK
Leadership roles in learned societies or professional bodies
- 2019-2024 Secretary General, European Association for Vision and Eye Research.
- 2019-2024 Representative for European Association for Vision & Eye Research on EU-EYE Board.
- 2018- 2020 Invited Member of the James Lind Alliance Priority Setting Partnership Steering Board: “Rare Mitochondrial Diseases”.
- 2016 - 2018 National Ophthalmology Specialty Lead for Wales.
- 2016 - 2018 Member of the UK Specialty Lead Panel for Ophthalmology Trials.
- 2014 - 2017 Member of the VISION 2020 UK Eye Research Committee.
- 2012- 2014 Lead Principal Investigator and Co-ordinator of the MRC Mouse Eyes & Vision Consortium.
- 2012 - 2017 Member Steering Committee, UK Eye Genetics Group.
- 2012 - 2013 Royal College of Ophthalmologists Representative on James Lind Alliance Priority Setting Partnership Steering Committee: “Sight Loss and Vision”.
- 2013 Invited Faculty Member, European Neuromuscular Consortium, Naarden, Holland.
- 2011 - 2016 Programme Secretary, European Association for Vision and Eye Research.
- 2009 - 2010 Vice President, European Association for Vision and Eye Research.
- 2004 - 2009 Section Chair for Molecular Biology/ Genetics/ Epidemiology, Board of European Association for Vision and Eye Research (EVER).
Editorships of journals
- 2013- present: Associate Editor, Editorial Board of Acta Ophthalmologica,
- 2020- present: Associate Editor Therapeutic Advances in Rare Disease
Guest editorships of books or special editions of journals
- 2013 Guest Editor for Drug Discovery Today: Disease Models
Other examples of leadership in the academic community
- 2008 & 2011 Jury member, Belgian Ophthalmology Research Prize.
- 2004 & 2009 Jury member, College of Ophthalmologists Research Prize.
Leadership roles in industry
- Expert Panel Member, Novartis Gene Therapy for RPE65 Leber’s congential amaurosis, London 2018
- Expert Panel Member, Chair and Invited Speaker at Mitochonrial optic neuropathies“, Santhera Pharmaceuticals, Prague, 2019
Review of papers for scientific journals
I regularly review papers for scientific journals, including ophthalmology and neuroscience journals- Brain, Investigative Ophthalmology & Vision Science, Archives of Ophthalmology, The British Journal of Ophthalmology, Eye, Ophthalmic Research, Neuro-ophthalmology, Acta Ophthalmologica and Experimental Eye Research and genetics journals- Human Molecular Genetics, American Journal of Human Genetics, Journal of Medical Genetics, Human Genetics, European Journal of Human Genetics and Ophthalmic Genetics.
I also regularly review Grant Applications for national bodies- The MRC, The Wellcome Trust, Fight for Sight, The Macular Disease Society, The Guide Dogs for the Blind Association, The Iris Fund, the National Eye Research Center and international bodies, including, the Swiss National Science Foundation and Association Francaise contre les Myopathies.
Publications
We are currently unable to retrieve the list of publications. Visit our institutional repository.Teaching
Undergraduate Optometry Teaching
I lecture and examine final year optometry students on abnormal ocular conditions and case based learning.
Postgraduate Teaching in Ophthalmology
I participate in postgraduate teaching in ophthalmology at the University Hospital, Wales.
https://www.fightforsight.org.uk/news-and-articles/articles/news/international-womens-day-2023/
Research Interests
My research focus is on the role of mitochondria in the pathophysiology of neurodegenerative disease. My focus has been inherited optic neuropathy, with an emphasis on generating model systems to study retinal ganglion cell (RGC) loss and inner retinal degeneration, which occurs as a primary phenomenon in a number of human genetic diseases.
We are studying RGC loss and rescue in vitro and in vivo, and the sequelae of this neurodegeneration on inner retina. To this end, we have been utilising retinal ganglion cell lines and primary RGCs, to explore the effect of mitochondrial fusion and fission genes on cell viability and the mechanism of cell death. We are also exploring the role of neuroprotective agents. OPA1 is known to bind to the inner mitochondrial membrane, and when mutated it is believed that the normal balance of mitochondrial fusion and fission is disturbed and programmed cell death is initiated by the loss of mitochondrial membrane potential and the release of cytochrome c. We are also investigating the role of the OPA3 gene in both RGC loss and cataract formation. OPA3, like OPA1, is thought to have a role in mitochondrial membrane dynamics, and when mutated in the human, a complex neurodegenerative disease, comprising optic neuropathy secondary to RGC loss, cataract and neuromuscular degeneration, arises.
Current clinical trial recruitment
A prospective natural history study of patients with autosomal dominant optic atrophy (FALCON)
Status Open to recruitment: research co-ordinator Ms Hayley Westwood.
Background Autosomal Dominant Optic Atrophy (ADOA) is caused primarily by mutations in the OPA1 gene found on Chromosome 3. The OPA1 gene takes care of the production of the OPA1 protein. The OPA1 protein is found inside mitochondria, a part of the cell involved in making energy available so that the cell can function normally. Problems with vision are sometimes due to mitochondria not working properly. Due to a shortage of energy, the nerve cells in the eye cannot send visual information to the brain.
By collecting information from as many patients with ADOA through a natural history study, the sponsor of this study (Medpace UK (Stoke Therapeutics) hopes to learn and gather more information about your experience with ADOA over several years, increasing our knowledge about the disease.
Objectives The primary objective of this study is to evaluate the rate of change in patients with Autosomal Dominant Optic Atrophy (ADOA).
Research aims The aim of this natural history study is to evaluate the rate of change for patients with ADOA, by completing eye and vision assessments, assessing quality of life and exploring factors associated with disease progression.
Who can take part? Individuals (aged (≥18 to ≤60 years old) with a diagnosis of Autosomal Dominant Optic Atrophy (ADOA) caused by mutations (changes) in the OPA1 gene.
What is involved? Participants will be asked to visit the Eye Clinic, University Hospital Wales for up to 5 visits over a 24-month period. The study visits will involve:
– Collecting information about medical history and medical conditions
–Genetic testing (cheek swab)
–Physical examinations and eye and vision assessments
– Completing quality of life (QOL) questionnaires
–Blood samples for analysis
Current Postgraduate Research Students
2019-2022 Fight for Sight Studentship Gloria Cimaglia, co-supervisor with James Morgan and Pete Williams. Title: “NAD in glaucoma neuroprotection”.
2021-2024 Mariia Grudina, Primary supervisor Marcela Votruba. Co-supervisors Ben Mead & Malgorzata Rozanowska. Title: "Human induced pluripotent stem cell models for the study and treatment of mitochondrial optic neuropathies".
2021-2024 Turkish Scholarship. Esmahan Durmez, co-supervisor with Ben Mead. Title: ""Therapeutic testing of exosomes for retinal disease".
Research Alumni
Post- doctoral Research Associates
- Dr Vanessa Davies
- Dr Ruby Grewel
- Dr Andrew Hollins
- Dr Kate Powell
- Dr Terry Smith
- Dr Kathy Beirne
- Dr Carmine Varrachio
- Dr Irina Erchova
- Dr Dinesh Kumar Kandaswamy, Newton International Fellow
- Dr Matthieu Trigano
- Dr Thomas Freeman
Technical Assistants
- Elaine Taylor
- Sharon Seto
- Pascale Aeschlimann
Former PhD Students
- Dr Jack Sheppard
- Dr Gosia Piechota
- Dr Jennifer Davies
- Professor Pete Williams
- Dr Carolyn Walker
- Dr Kathy Beirne
- Dr Carmine Varricchio
- Dr Shanshan Sun
Professional Training Scheme
- Rebecca Thirgood
EVER Foundation Fellows
- Dr Pratyusha Ganne BM BCh FRCOphth
- Dr Deepti Mahajan MD FRCOphth
Summer Students
Dr Marrios Sarros MD, Dr Costas Karabatsas MD, Yip Wan Fen NSc, Laura Byrne, Amanda Mui, Rebecca Watts, Roshini Joseph, Oliver Coppleston, Christopher Man, Kestutis Satkus
Recent & current grant funding
2019-2021 Academy of Medical Sciences Newton International Fellowship. Host M Votruba. Fellow Dr Dinesh Kumar Kandaswamy. “Near-infrared light therapy as a therapeutic regimen for inherited optic neuropathy.”
2019-2022 Fight for Sight Studentship. Morgan JE, Votruba M, Williams P. “NAD therapy in glaucoma”.
2019-2020 Wellcome Trust ISSF3 Consolidator Award. C Varrachio. M Votruba, Sponsor Dr B Newlands.
2019-2020 Wellcome Trust ISSF3 Cross Disciplinary Award. Light for Sight – neuroprotection in mitochondrial optic neuropathy. M Votruba, M Rozanowska, J Hicks, S Armstrong.
2020-2021 National Eye Research Centre Project Grant. “Sustained release formulations for new drugs in the treatment of mitochondrial optic neuropathies.” Votruba M, Brancale A, Rozanowska M and Heard C.
Research Collaborators
International
Professor Anne A. Knowlton, M.D., Professor of Medicine and Medical Pharmacology, Molecular & Cellular Cardiology, University of California, Davis, California, USA.
Professor Don Newmeyer, PhD, La Jolla Institute for Allergy and Immunology, La Jolla, CA , USA.
Professor Peter Nuernberg, PhD, Cologne Centre for Genomics, University of Cologne, Germany.
Professor Sayan Roy, Ph.D., FARVO, Professor of Medicine, Section of Diabetes, Endocrinology & Nutrition & Professor of Ophthalmology, Boston University School of Medicine, USA.
Professor Pete Williams, Assistant Professor, Dept. of Clinical Neuroscience, Section of Ophthalmology and Vision, Karolinska Institute, Stockholm
National
Dr Patrick Yu-Wai-Man, MRC Clinician Scientist, Mitochondrial Research Group, The Medical School ¨University of Cambridge and UCL, Moorfields Eye Hospital
Professor Ron Douglas, Professor of Visual Science: Deputy Head of Department, City University London
Professor Jo Poulton, PhD MRCP, Professor of Mitochondrial Genetics, John Radcliffe Hospital, University of Oxford
Professor Tim Wells, PhD, School of Bioscience, Cardiff University.
Professor Andrea Brancale PhD and Dr Charles Heard PhD, Welsh School of Pharmacy and Pharmaceutical Sciences, Cardiff University
Supervision
Current students
2019-2022
Fight for Sight Studentship Gloria Cimaglia, co-supervisor with James Morgan and Pete Williams. Title: “NAD in glaucoma neuroprotection”.
2021-2024
Mariia Grudina, Primary supervisor Marcela Votruba. Co-supervisors Ben Mead & Malgorzata Rozanowska. Title: "Human induced pluripotent stem cell models for the study and treatment of mitochondrial optic neuropathies".
2021-2024
Turkish Scholarship. Esmahan Durmez, co-supervisor with Ben Mead. Title: ""Therapeutic testing of exosomes for retinal disease".
I am interested in supervising PhD students in the areas of:
- Role of mitochondria in neurodegeneration
- Novel therapies for mitochondrial optic neuropathies
- iPS cells for the testing of novel therapy of mitochondrial dysfunction
- Mitochondrial damage in age related macular degeneration
- Quality of life in patients with inherited retinal and optic nerve disease, utility of novel therapies
Current supervision
Past projects
2017-2020
Chinese Scholarship Council/ Vice Chancellor’s Scholarship. Shanshan Sun. Primary Supervisor. Co-supervised with Prof Frank Sengpiel and Dr Irina Erchova. Title: “Mitochondrial dynamics in neurodegeneration.”
2016-2019
NRN Joint Cardiff School of Pharmacy and School of Optometry & Vision Sciences Studentship. Carmine Varricchio. Primary Supervisor. Co-Supervised with Prof Andrea Branca, Dr Charles Heard and Dr Malgorzata Rozanowska. Title: “Intelligent drug design in mitochondrial optic neuropathy:”
2014-2017
College of Optometry Studentship. Rupal Shah. Second co-supervisor, with Prof Jez Guggenheim. Title: “Discovery of genetic determinants for refractive error.”
2013-2016
Fight for Sight Studentship. Kathy Beirne. Primary Supervisor. Co-Supervised with Prof J Morgan & Dr M Rozanowska. Title: "Light therapy for mitochondrial optic neuropathy".
2013-2015
Ghanean Education & Training Fund: Enyam Mornay. Primary Supervisor. Co-Supervised with Dr Tom Margrain. Title: “Biomarkers of early disease and progression in inherited optic neuropathy”.
2011-2013
BBSRC Studentship: Caroline Walters. Primary Supervisor. Co-Supervised with Dr Malgorzata Rozanowska. Title: “Therapeutic rescue of Opa1 mutants”.
2009-2012
MRC Studentship: Peter Williams. Primary Supervisor. Co-Supervised with Professor James Morgan. Title: “Role of OPA1 in retinal ganglion cell dendritic remodeling.”
2006-2009
MRC/ BBSRC Studentship: Jennifer Davies. Primary Supervisor. Co-Supervised with Dr Andrew Quantock. Title: “Structure and function of the opa3 protein: disease mechanisms at the inner mitochondrial membrane.”
2005-2008
School Vision Sciences Studentship: Malgorzata Piechota. Primary Supervisor. Co-Supervised with Prof. Mike Boulton. Title: "Investigating the pathophysiology of inherited optic atrophy: the phenotypic characterisation of novel murine targeted opa1 and opa3 mutants, functional studies and novel rescue strategies".
2004-2007
MRC Studentship: Jack Sheppard. Primary Supervisor. Co-Supervised with Prof. Keith Meek. Title: "Genetic and structural pathogenesis of keratoconus: the role of the VSX1 gene".